Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion (NYSE:AORT) will participate in two investor conferences in August 2026. Management will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 9:30 a.m. ET at the InterContinental Boston Hotel, with a live webcast and 90-day archive on Artivion's investor webpage. The company will also hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026, though no webcast will be available.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, July 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 46^th Annual Growth Conference on Wednesday, August 12, 2026 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 9:30 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website. 

Artivion management will also be participating in investor meetings at the 11^th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. Due to the format of this event no webcast will be available.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston
Executive Vice President,	Phone: 332-895-3222
Chief Operating Officer &	investors@artivion.com
Chief Financial Officer
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302836914.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (NYSE:AORT) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

Artivion will present on Wednesday, August 12, 2026, at 9:30 a.m. ET. According to Artivion, the session takes place at the InterContinental Boston Hotel as part of the 46th Annual Growth Conference.

How can investors access the Artivion (AORT) webcast for the Canaccord Genuity 2026 conference presentation?

Investors can access a live webcast on Artivion’s website under the Investors page. According to Artivion, an archived replay of the presentation will also be available for 90 days on the same site.

Will there be a webcast for Artivion’s meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference in 2026?

No, there will be no webcast for Artivion’s participation at the Needham conference. According to Artivion, the event’s 1x1 meeting format does not include public webcast access for investors.

On what date will Artivion (AORT) attend the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference?

Artivion management will participate in investor meetings on Tuesday, August 11, 2026. According to Artivion, these meetings are part of the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference format.

Where can investors find more information about Artivion (NYSE:AORT) and its investor events?

Investors can visit www.artivion.com and navigate to the Investors page for event webcasts. According to Artivion, the site also provides broader company information and archived conference presentations.

Who is the investor relations contact for Artivion (AORT) regarding the August 2026 conferences?

According to Artivion, investor relations are handled by Gilmartin Group, contact Brian Johnston at 332-895-3222 or investors@artivion.com. Company executive contact is Lance A. Berry at 770-419-3355.